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The  ﬁrst  nationwide  orthopaedic  registry  was  created  in Sweden  in 1975  to  collect  data  on  total  knee
arthroplasty  (TKA).  Since  then,  several  countries  have  established  registries,  with  varying  degrees  of
success.  Managing  a registry  requires  time  and  money.  Factors  that  contribute  to successful  registry
management  include  the  use  of  a single  identiﬁer  for  each  patient  to ensure  full traceability  of  all  proce-
dures  related  to a given  implant;  a long-term  funding  source;  a contemporary,  rapid,  Internet-based  data
collection  method;  and  the  collection  of  exhaustive  data,  at least  for innovative  implants.  The  effects  of
registries  on  practice  patterns  should  be evaluated.  The  high  cost  of  registries  raises  issues  of  indepen-
dence  and  content  ownership.  Scandinavian  countries  have  been  maintaining  orthopaedic  registries  for
nearly  four  decades  (since  1975).  The  ﬁrst  English-language  orthopaedic  registry  was  not  created  until
1998  (in  New  Zealand),  and  both  the  US  and  many  European  countries  are  still  struggling  to establish
orthopaedic  registries.  To  date,  there  are  11  registered  nationwide  registries  on  total  knee and  total  hip
replacement.  The  data  they  contain  are  often  consistent,  although  contradictions  occur  in some  cases  due
to major  variations  in  cultural  and  market  factors.  The  future  of registries  will  depend  on  the  willingness
of  health  authorities  and  healthcare  professionals  to support  the creation  and  maintenance  of  these  tools.
Surgeons  feel  that  registries  should  serve  merely  to compare  implants.  Health  authorities,  in contrast,
have  a strong  interest  in  practice  patterns  and  healthcare  institution  performances.  Striking  a  balance
between  these  objectives  should  allow  advances  in  registry  development  in the  near  future.
©  2014  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
The ﬁrst registry on joint prostheses was created 45 years ago
in 1969) at the Mayo Clinic in Rochester, MN,  USA. In 1975, efforts
ed by Professor Bauer led to the establishment in Sweden of the
rst nationwide registry, which collected data on total knee arthro-
lasty (TKA) [1].
The objective of this work is to review the current status of
rthopaedics and traumatology registries, to discuss their impact,
nd to highlight their limitations. Traumatology registries are
ew in number, largely conﬁned to Scandinavian countries, and
esigned only for epidemiological purposes. This paper is therefore
onﬁned to nationwide registries of TKA and total hip arthroplasty
THA), which are the oldest and most informative.∗ Correspondence. 39, avenue Daumesnil, 75012 Paris, France.
el.: +33 1 69 103 059/+33 6 72 012 494; fax: +33 1 69 103 133.
E-mail addresses: c.delaunay@clinique-yvette.com, drc.delaunay@orange.fr
http://dx.doi.org/10.1016/j.otsr.2014.06.029
877-0568/© 2014 Elsevier Masson SAS. All rights reserved.2. What is a registry?
In France, a decree issued on 6 November 1995 by the National
Registry Committee (Comité national des registres, CNR) deﬁnes a
“qualiﬁed registry” as “a continuous and exhaustive collection of
nominative data about one or more health-related events in a geo-
graphically deﬁned population, by a team having speciﬁc expertise,
to be used for research and public health studies”. Unfortunately,
article 2 of this decree proscribes the creation of registries for
implantable medical devices and the collection of outcome data
on implant recipients [2]. This legislative barrier is among the
main reasons France is far behind other countries in the area of
orthopaedic implant registries.
3. How is a registry created?
Orthopaedic and traumatology registries collect data from a
single or multiple sites, within a speciﬁc geographic region or
nationwide. Only a limited amount of information is collected, to
reﬂect the limited purpose of the registry. Thus, the minimum
dataset established by the International Society of Arthroplasty
Registries (ISAR) contains only 14 items [3].
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Longitudinal data are collected to assess the outcome of the
mplant(s) in each patient. In contrast to disease-based registries,
hich collect the vital status of the patients, implant registries
ssess the survival of the implants. Thus, the death of a patient
hose implant is still in place is classiﬁed as a probable or relative
uccess of the implant procedure. Implant revision is the only indis-
utable endpoint, although it is affected by a number of factors (e.g.,
atient health status, inadequate implant monitoring, or missed
iagnosis of implant failure). The term “revision” must, however,
e clearly deﬁned. The Swedish registry uses the following strin-
ent deﬁnition: any new surgical procedure during which one or
ore prosthesis components are replaced, removed, or added. The
orwegian registry, in contrast, deﬁnes revision as the removal of
ll the implant components and therefore classiﬁes patellar resur-
acing, for instance, as a simple re-operation.
The key to ensuring the efﬁcacy of an implantable medical
evice registry is the use for each patient of a single identiﬁer,
referably the statutory health insurance number or national iden-
ity number. This identiﬁer ensures that a primary prosthesis
mplanted at a given institution at a given date can be connected
o subsequent revision of the implant at a different institution.
ecording the side is informative in patients with bilateral arthro-
lasty. This automatic cross-referencing function is effective only
f data collection is exhaustive.
When comparing implant performance for benchmarking pur-
oses, survival curves are the best tool. To plot survival curves,
nformation must be available on the vital status and, therefore,
he identity of the patients. Many countries have laws forbid-
ing the collection of data on patient identity. The Australian
egistry circumvents this problem by using the revision rate per
00 observed component years, which allows comparative analy-
es without knowledge of patient death dates. The same method
s used in the British registry (patient time incidence rate), Euro-
ean Arthroplasty Register (EAR), and French SoFCOT THA registry
https://sofcot.memdoc.org/) [4,5].
Despite these limitations, registries allow epidemiological and
emographic studies, as well as comparisons of outcomes across
mplants and institutions within a country. Registries are designed
o collect information from all surgeons, instead of only from
he highly specialized groups that contribute most of the studies
ublished in the international medical literature. Thus, registries
rovide a more accurate view of the real-life healthcare provided
o the population.
Management of a registry requires large amounts of time and
ther resources, most notably when exhaustive data are collected.
or many registries (e.g., in Sweden and Finland), the registries
ere created under the impetus of professional societies. Else-
here (e.g., in Canada and the UK), the health authorities required
hat healthcare institutions establish registries and, therefore, con-
ributed to the data recording effort. In many cases, these two
ituations followed one upon the other.
. Historical overview
Whereas Scandinavian countries have been maintaining
rthopaedic registries since 1975, the ﬁrst English-language
rthopaedic registry was not created until 1998 (in New Zealand)
nd both the US and many European countries are still struggling to
stablish similar tools. To date, there are 11 registered nationwide
egistries of TKA and THA (Table 1).
.1. The Swedish Knee Arthroplasty Register and the Swedish Hip
rthroplasty Register
The Swedish Knee Arthroplasty Register created in 1975
http://www.knee.se) and the Swedish Hip Arthroplasty Registerurgery & Research 101 (2015) S69–S75
created in 1979 (http://www.shpr.se/en/) remained conﬁdential
until 1989, when their results were ﬁrst reported in an international
journal [6]. Since then, they have gained increasing international
prominence, as their contents are described in an English-language
report every 2 years [7]. Sweden now has 73 nationwide registries,
whose total cost of 35.6 million D per year is entirely covered by
non-industrial sources [2].
4.2. The Finnish National Arthroplasty Register
The Finnish National Arthroplasty Register (http://www.ﬁmea.
ﬁ/frontpage) was  started in 1980 to collect data on both THA and
TKA. Data reporting to the register was  initially on a voluntary basis
but has been mandatory since 1997. The THA revision rate was
19.6% in 1999 when the population of Finland was 5.1 million [8]
and remained as high as 15.2% in 2001–2010.
4.3. The Norwegian Arthroplasty Register of THA
The Norwegian Arthroplasty Register of THA (http://
wwwnrlweb.ihelse.net/eng/) was  created in 1987. It is ill suited to
comparisons of implants and collects outcomes of the few thou-
sand THA procedures performed annually in this small country
with a population of 4.5 million. In 2003, the 10-year probability
of non-revision for 78,534 primary THA procedures was  88.6% and
the revision rate was  14.5% [9].
4.4. The Danish Hip Arthroplasty register
The Danish Hip Arthroplasty register (http://www.dhr.
dk/ENGLISH.htm) was ﬁrst envisioned in 1989 but was not
initiated until 1995. The ﬁrst report was  for the 1995–1999 period
and showed a 15.5% revision rate [10]. This registry now has nearly
100 000 patients and the number of new entries is 9000 per year
in this country with a population of 5.3 million. Denmark has 60
to 70 accredited clinical registries, which are entirely funded by
regional taxes, their total cost being 6.5 million D [2].
4.5. The New Zealand Joint Registry for THA and TKA
The New Zealand Joint Registry for THA and TKA (http://www.
nzoa.org.nz/nz-joint-registry) started in 1998 was the ﬁrst English-
language arthroplasty registry. It contains only limited data on
arthroplasty outcomes. For the 5579 THA procedures done in 2003,
the revision rate was 13.3%, and the revision rate in the latest report
was 11.5%.
4.6. The Australian Orthopaedic Association (AOA) National Joint
Replacement Registry
The Australian Orthopaedic Association (AOA) National Joint
Replacement Registry (https://aoanjrr.dmac.adelaide.edu.au/) ini-
tiated in 1999 is funded by the Ministry of Health. Data collection
was extended to the entire country in 2007 with funding via a fee
included in the price of each implant. With over 266 000 primary
THA procedures, this registry complements the Swedish registry,
as only 18% of all implants are cemented and some implant models
are unavailable on the Swedish market.
4.7. The nationwide Canadian Joint Replacement Registry (CJRR)The nationwide Canadian Joint Replacement Registry (CJRR)
established by the Canadian Institute for Health Information (CIHI)
(http://www.cihi.ca/cjrr) was  started in 2001 as an extension of
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Table  1
Chronology and recent revision rates in the 11 main registries of total hip and knee arthroplasty.
Registry Site Year created Study period
n primary procedures
n revisions Revision rate %
Rev/(primary + Rev)
Sweden TKA
THA
1975
1979
1975–2011
188,093
1979–2011
347,129
2001–2010
5146
34,981
NS
9.2
Finland THA & TKA 1980 2001–2010
H: 71,318
K: 83,575
12,750
5930
15.2
6.6
Norway THA 1987 1987–2012
147,401
24,669 16.7
Denmark THA 1995 1995–2012
120,988
19,282 13.7
New  Zealand THA & TKA 1998 1999–2012
H: 85,769
K: 64,799
12,731
5089
12.9
7.3
Australia THA & TKA 1999 1999–2012
H: 266,465
GK: 429,228
44,729
35,620
14.4
7.7
Canada THA & TKA 2001 2010–2011
H: 38,513
K: 47,113
4303
3652
10.2
7.2
Romania THA 2001 2001–2011
76,575
4713 5.8
England/Wales THA & TKA 2003 2006–2011
H: 392,109
K: 415,216
36,364
NS
8.5 (6% in 2011)
The
Netherlands
THA & TKA (1992, failure)
2007
2007–2011
H: 105,455
K: 79,272
11,283
5982
9.7
7
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lHA: total hip arthroplasty; TKA: total knee arthroplasty; NS: not speciﬁed; H: hip
unicompartmental patello-femoral or tibio-femoral prosthesis) and/or TKA depend
 simple arthroplasty counting system established in 1994. In
010–2011, this registry still covered only 43.8% of the country.
.8. The Romanian Arthroplasty Register
The Romanian Arthroplasty Register (http://www.rne.ro/?
ang=en) of THA is the ﬁrst registry created in Eastern Europe. Only
HA procedures are recorded. The number of procedures remains
imited (8828 primary THAs in 2011).
.9. The National Joint Registry of England
The National Joint Registry of England and Wales (http://
ww.njrcentre.org.uk/njrcentre/default.aspx) was  set up in 2002
ased on experience gained with a preliminary regional registry
tarted in 1990 in the Trent region of England [11]. One must keep
n mind here the episode of the Capital HipTM prosthesis marketed
y 3 M and chieﬂy used in the UK in the 1990s. Over 6 years elapsed
efore the titanium-alloy femoral stem was recognized to result
n a high failure rate and corrective measures were taken for the
500 patients carrying this implant. This health disaster prompted
he British health authorities to create a THA registry for England
nd Wales in 2001 [12]. Thus, whereas the Trent regional registry
as a local experiment, the national registry was controlled in
ractice by the health authorities, a fact that raised considerable
oncern in the orthopaedic community [13].
.10. The Dutch Arthroplasty Register (LROI) of THA and TKA
roceduresThe Dutch Arthroplasty Register (LROI) of THA and TKA pro-
edures (http://www.lroi.nl/en/home) was initiated in 2007. After
 failed attempt in 1992, 15 years elapsed before the Nether-
ands Orthopaedic Association (NOV) obtain public funding, afteroral prosthesis and/or THA depending on the registry; K: knees, partial prosthesis
n the registry.
implementation of the registry was included among Good Profes-
sional Practice criteria.
5. Usefulness of registries
5.1. Post-marketing surveillance of implantable medical devices
Innovations are introduced in countries where freedom of pre-
scription and research still allow their evaluation, via prospective
studies that comply with legislation designed to protect volunteer
patients. Although registry data are less satisfactory, prospective
clinical studies are challenging to perform in the ﬁeld of pros-
thetic surgery, and the considerable time needed to obtain and
disseminate their results precludes the effective detection of early
failure of implantable medical devices [14]. According to Roberts-
son, to obtain 80% power for detecting a signiﬁcant difference for
an implant whose revision rate is 30% above the mean (e.g., 6.5%
instead of 5%), 4000 patients must be randomised then followed-
up for 10 years [1]. Web-based registries constitute an effective
solution to this problem [15]. Recording new implantable medical
devices in registries allows comparisons of their early outcomes
to those of the reference standard implants, thereby ensuring the
detection of suboptimal performance within a few years. A few
examples are presented below.
The Norwegian Arthroplasty Register detected poor perfor-
mance of Boneloc® bone cement by showing a downward slope
in the survival curves of well-known implants that had been con-
sistently providing satisfactory outcomes [16]. The problem was
identiﬁed within 3 years and Boneloc® was permanently removed
from the market.
The Inter-opTM (Sulzer, Austin, TX, USA) used in the USA is
another illustrative example. The Swedish registry identiﬁed the
failure of this device as early as 1998 by showing a 16.7% revision
rate within the ﬁrst 6 months, although the device was  recalled
only 14 months later. This lost time and lack of reactivity of the
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rthopaedic community related to the absence of a rapid and effec-
ive information system generated strong criticism [17].
In the Finnish registry, of 10 TKA implants recently introduced
n the market, 4 had abnormally high early revision rates, indicat-
ng the existence of a learning curve [18].
In 2005, the NJRR showed abnormally high 2-year revision rates
ranging from 27.7% to 49.3%) for four TKA devices introduced in
003 and having a femoral component made of Oxinium®. These
evices were removed from the market.
In 2007, the NJRR reported an abnormally high revision rate after
se of the ASRTM resurfacing system (DePuy Orthopaedics, Warsaw,
N, USA). Despite the implementation of a training programme, this
evice was removed from the Australian market in 2009 then from
he worldwide market.
The most striking ﬁnding from the NJRR is that all THA and
KA innovations introduced in 2003–2007 failed, although they had
btained marketing licenses via procedures similar to those used
n Europe, proving that these procedures are inadequate [19].
.2. Use of registries to generate scientiﬁc evidence
Over more than two decades, registries have allowed many tech-
ical advances. For instance, data from the Swedish THA registry
ocumented advances in second-generation cement ﬁxation and
he adverse impact of older age at primary THA, with an overall 30%
ecrease in 20-year survival among patients younger than 50 years
ompared to those older than 75 years.
In 2009, the team responsible for the European Arthroplasty
egister (EAR) initiated the Quality of Literature in Arthroplasty
QoLA) project that compares registry data to the data in the inter-
ational literature. After THA, the mean revision rate was 1.29 per
00 observed component years [20]. This approach also conﬁrmed
he high quality and integrity of French articles on THA [21].
Information on a number of public health issues can be obtained
nly by very long-term epidemiological monitoring. More than 15
ears of data collection in the Finnish registry were required to
liminate a relationship between metal-on-metal bearings and the
evelopment of certain cancers [22].
The Swedish TKA registry recently showed a correlation
etween younger age at arthroplasty and higher mortality from
ardiovascular, gastrointestinal, and genitourinary diseases. This
esult indicates a need for close monitoring of patients who
ndergo arthroplasty at a young age [23].
.3. Cost-saving effects
In Sweden, in 2002, the cost of THA revision was estimated at
1,700 US $. Therefore, a 1% decrease in the number of revisions
ould save 1,368,900 US $ [24]. The Australian NJRR showed revi-
ion rate decreases from 14.8% to 11.1% for THA and from 10.4% to
.9% for TKA over a 4-year period, corresponding to a cost decrease
f 44.6 million Australian $ [2]. In the US, a 5% decrease in revision
ates would save about 30 million US $ per year [14].
. Limitations of registries
Even the exemplary Swedish THA registry has a number of lim-
tations, which are found in variable degrees in other national
egistries. Comparative analyses long focused solely on primary
ip osteoarthritis and used a single endpoint, namely, revision
or aseptic loosening, creating major obstacles to comparisons
ith the international literature. The registry contains little or
o cases for many implant models, as implants associated with
nadequate outcomes were removed from the Swedish market.
hus, in 2011, three implants accounted for 97.6% of all cementedurgery & Research 101 (2015) S69–S75
THAs in the registry: Lubinus-SPIITM (Link), 55.1%; MS30TM (Zim-
mer), 11.9% and ExeterTM polished (Stryker), 11.6%. Many reliable
implants recognized as valid by the international community are
completely absent from the Swedish registry: examples include
AMLTM (DePuy), Zweymüller-AlloclassicTM (Zimmer), Charnley-
KerboullTM (Stryker), and TaperlocTM (Biomet). These implants
cannot be evaluated based on the registry.
The ability of the Swedish THA registry to improve professional
practice has ﬂuctuated over time. Thus, the revision rate in Sweden
increased from 8.3% in 2002 to 9.2 in 2011. However, an unexpected
trend in practices has been noted in Sweden, with 3% of cementless
THA procedures in 2002 and 17% in 2011, in contradiction with
the strong historical recommendation from the Swedish registry to
consistently use cement ﬁxation.
As the results obtained in each region and institution are avail-
able to the public, patients can make informed choices. However,
this system can limit the willingness of surgeons to innovate,
as they may  prefer to perform well-established procedures and
implants to comply with the precautionary principle. The Amer-
ican media shine a strong spotlight on problems with implants. In
the US, the THA revision rate was as high as 18% and 52% of proce-
dures were done by surgeons who  performed fewer than 10 THAs
per year, with higher complication rates [25]. In the UK, the pub-
lic release of registry data is generating active controversy in the
orthopaedic community [26].
Registries may  fail to provide effective warning signals in the
ﬁrst few years after their creation. A case in point is the Eng-
land/Wales NJR registry created in 2003, the year the ASRTM
resurfacing system (DePuy) was introduced [4]. Despite a ﬁrst alert
in 2005 followed by conﬁrmation in 2008, the device was  not
removed from the market until 2010, after two  lost years, creating
a massive media blitz.
7. Divergences and convergences across registries
Registry data must be subjected to close scrutiny, and each def-
inition and table of results must be analysed with care. In addition,
under the combined inﬂuence of demographics and adherence vari-
ations, the number of implants included per year varies 20-fold.
Finally, the international usefulness of some registries is limited by
the lack of availability of an English-language version (Danish and
Dutch registries).
7.1. THA registries
A 2009 comparison of data from nine THA registries showed
that the mean annual number of primary THA procedures was
133/100,000 population, with major variations across patient age
groups, of up to 3.4-fold for the 55–64 year group between New
Zealand and Portugal [27]. Fixation methods varied widely, with
cementless implants contributing 17% of THAs in Sweden, 40% in
Finland, and 89% in Emilia-Romagna (Italy).
For a given type of implant, survival varied across registries
from culturally similar countries. For instance, 10-year survival
of the ExeterTM (Stryker) implant was 96% in Sweden compared
to only 92% in Finland, due to differences in the redeﬁnition of
revision between these two registries (http://www.shpr.se/en/ and
http://www.ﬁmea.ﬁ/frontpage, respectively).
Table 2 compares the frequencies of the ﬁve main reasons for
THA revision in four major national registries and a French prospec-
tive study [28]. Aseptic loosening remains the main reason for
primary THA revision, with variations from 29.9% of cases in Aus-
tralia to 58.4% in the UK.
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Table  2
Comparison of the frequency of the ﬁve leading reasons for total hip arthroplasty revision in four major national registries and a prospective study by the SoFCOT [28].
Registry/SoFCOT study Year(s) Percentage of revisions with each reason
Aseptic loosening Dislocation (rank) Infection (rank) Peri-prosthetic fracture Pain
Swedish 2011 58.4 11.2 (3) 13.9 (2)
Australian 2011 29.9 27.6 (2) 16.7 (3) 14.7 2
England/Wales 2011 42 13 (3) 12 (4) 8 24
New  Zealand 2010 41 30.6 (2) 13.2 (3) 9.5 10.7 (4)
 (5) 
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OFCOT data in italic are not provided by a national register but a multicentre pros
Since the late 1990s, all registries have consistently documented
 marked improvement in the performance of last-generation
ementless implants.
.2. TKA registries
Comparisons of 2006 reports from the most representative reg-
stries indicate shared epidemiological and demographic trends.
omen  predominated in all registries. Mean age was about
0 years but showed a steady decline related to an increase in the
umber of TKAs performed between 45 and 54 years of age. Knee
steoarthritis was by far the main reason for TKA; the proportion
f patients with inﬂammatory disease ranged from 4% in Canada to
3% in Finland. Fully cemented ﬁxation was used in the vast major-
ty of cases, the only exception being the Australian registry, with
3.8% of cementless TKAs. Unicompartmental knee arthroplasty
sually contributed fewer than 10% of cases (11.8% in Australia and
2% in Norway). Finally, aseptic loosening was the main reason for
evision, with 20% (UK) to 44% (Sweden) of cases. Absence of patel-
ar resurfacing was consistently associated with a higher risk of
evision. The latest revision rates were remarkably similar across
ountries (6.6% in Finland and 7.7% in Australia) (Table 1).
National preferences for speciﬁc TKA devices depend heavily on
he local orthopaedic culture and market share distribution among
mplant manufacturers. These factors are at least as powerful as
mplant performance. Table 3 reports the three most commonly
sed implants in each registry in 2006. The data from the four
candinavian registries indicate a high level of practice uniformity,
ith each implant trio having about two-thirds of the relevant
ational market. The Norwegian registry, however, had a differ-
nt trio (Proﬁx®, LCS®, and Genesis®) that was very similar to that
sed in Australia.
.3. Collaboration between THA and TKA registries
As early as 2006, the number of TKAs increased faster than the
umber of THAs. A larger number of TKAs than THAs was performed
ach year in Finland, Australia, Canada, and England/Wales. In all
egistries, revision rates were about 50% lower for TKA than for THA
Table 1). The largest difference was reported in 2004 in the Medi-
are population in the US, with revisions in 7.3% of TKA patients
nd 18% of THA patients [29].
The Nordic Arthroplasty Register Association (NARA) created
n 2007 is a collaboration among the TKA and THA registries
f Sweden, Denmark, and Norway [30]. Of the 280,201 primary
HAs, 89% were cemented in Sweden and 46% in Denmark. Over-
ll implant survival was longer in Sweden (Table 4). The three
egistries showed concordant results for three points. The two
ost widely used THA devices were the cemented Lubinus-SPTM
Link) and ExeterTM (Stryker) implants. The three leading reasons
or revision were aseptic loosening (63% to 75% across countries),
islocation (5.8% to 12%), and infection (6.7% to 11%).
The NARA collected data on 151,814 primary TKAs. Denmark
ad a 76% rate of patellar resurfacing, compared to only 11% in11.2 (3) 11.8 (2) 1.3
e study.
Norway; and a 22% rate of cementless, compared to only 2% in
Sweden.
8. The future of registries
8.1. On the international scene
The creation of registries for implantable medical devices is
a major recommendation issued by EUCOMED, which represents
the medical technology industry in Europe. The goal is to shorten
the response time to alerts generated by post-marketing medical-
device surveillance, thereby minimising adverse events by ensuring
prompt elimination of defective devices from the market.
The European Federation of National Associations of
Orthopaedics and Traumatology (EFORT) contributes to promote
national registries, while respecting the distinctive characteristics,
culture, and options of each country. Since 2005, EFORT has
pooled data on speciﬁc implants collected in various countries.
Finally, ensuring uniformity of data collection in national registries
would allow worldwide comparisons and is an objective of the
International Society of Arthroplasty Registries (ISAR).
The explosive growth of prosthetic surgery predicted to occur
over the next few decades lends urgency to the achievement of
these objectives [31]. The creation of an implant registry in the US
is still in its preparatory stages, although the Food and Drug Admin-
istration created the International Consortium of Orthopaedic
Registries (ICOR) in 2011 [32]. The objective of the ICOR is to pool
data from existing national registries and to improve data collec-
tion uniformity in order to facilitate exchanges, most notably by
creating a universal bar code [33].
8.2. In France
In 2006, the SoFCOT created a THA registry similar to the
Swedish and Australian registries, with voluntary reporting (CNIL
approval #04-1277). The main requirements were as follows:
mandatory information of patients scheduled for arthroplasty;
rapid web-based data collection [15]; use of patient-speciﬁc iden-
tiﬁers (NIR or INSEE number) to ensure automatic identiﬁcation of
revisions and, above all, identiﬁcation of patients carrying implants
for which alerts are generated; statistical data analysis by a steer-
ing committee working with a stable group of experienced hospital
professionals; efforts to achieve exhaustive data collection in the
long-term, of which a prerequisite is a strong incentive from health
authorities; and prevention of data misuse via the maintenance of
a certain degree of independence.
Over 250,000 THA and TKA procedures are performed each year
in France. This large number of procedures translates into a cost of
several hundred thousand Euros per year to maintain a registry. No
professional society can obtain funding on such a large scale. The
only option to minimise costs is to rely on existing statistical data
management agencies. The SoFCOT therefore established a contract
with the Institute for Evaluative Research in Orthopaedic Surgery of
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Table 3
Registry data on techniques and implants used for primary unicompartmental or total knee arthroplasty in 2006.
Registry % Uni % patellar
replacement
Fully cemented Hybrid Cementless Three most often used
implants (study period)
Swedish 9.4% < 10% 98% 2% 0 AGC® , PFC Sigma® &
Free-Sam MIII®: 6%
(1995–2004)
Finnish < 10% NS 98% NS NS Duracon® , AGC V2® &
PFC, Sigma®: 58%
(1990–2004)
Norwegian 12% 15% ± 87% ± 11% ± 2% Proﬁx® , LCS® & Genesis
I®: 64%
(1994–2005)
Danish 5.5% 67.3% 74.4% 14.5% 10.3% AGC V2® , PFC® &
NexGen®: 64.3%
(1997–2005)
Australian 13.3% 41.5% 48.7% 27.5% 23.8% LCS® , Duracon® &
Genesis II®: 31%
(1999–2004)
Canadian 8% 73% 84% 12% 4% NS
England and
Wales
8% NS 83% 1% 7% PFC Sigma® , AGC® ,
NexGen®: 23%
(2003–2007)
NS: not speciﬁed.
Table 4
Comparison of data from the three Scandinavian registries in the Nordic Arthroplasty Register Association (NARA) [31].
THA Number of procedures % in the NARA dataset % postero-lateral approach % cemented
NARA 280,201 100 58.6 76
Swedish 140,821 50.3 60 89
Norwegian 70,138 25 24 79
Danish 69,242 24.7 91 46
TKA  Number of procedures % in the NARA dataset % patellar button Relative risk of revision (TKA only)
NARA 151,814 100 22.3 NS
Swedish 86,952 57.3 2 1
Danish  38,411 25.3 76 1.6
N
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tNorwegian 26,451 17.4
S: not speciﬁed; TKA: total knee arthroplasty; THA: total hip arthroplasty.
he Bern University, Switzerland, which has acquired considerable
xpertise in the ﬁeld since 1967.
Both professional societies and physicians must be actively
nvolved in maintaining registries. The Medical Specialties Feder-
tion (Fédération des spécialités médicales, FSM) is in charge of
chieving this objective. In addition to ankle prostheses, which have
een under close surveillance for 3 years via an observational reg-
stry of limited duration, THA (most notably with metal-on-metal
earings) and TKA are the two priorities for orthopaedic registries
equired by the French health authorities.
In application of chapter IX of the French law of 6 January 1978,
rojects involving the collection of personal data to be used for
ealthcare research must be submitted to an advisory commit-
ee on healthcare research data management (Comité consultatif
ur le traitement de l’information en matière de recherche en
anté, CCTIRS), which assesses the scientiﬁc method to be used.
hen, the project must be approved by the French Data Protection
uthority (Comission nationale de l’informatique et des libertés,
NIL). Finally, approval from the National Registry Committee
Comité national des registres, CNR), which relies on resources from
he National Institute for Health and Medical Research (Institut
ational de la santé et de la recherche médicale, Inserm) and French
ealth Watch Institute (Institut de veille sanitaire, InVS) is required
o obtain accreditation as a “qualiﬁed registry”.
One more major obstacle to the creation of effective registries
s the set of severe restrictions placed on the use of the NIR to iden-
ify patients. A decree from the State Council must be obtained11 1.4
to authorise the use of the NIR. One means of circumventing this
obstacle may  consist in using the national health identiﬁer (INS),
which is derived from the NIR using anonymisation techniques.
However, the application decree for the INS has not yet been issued
[2]. These administrative obstacles have contributed to the delay in
establishing effective registries in France.
Finally, strictly voluntary reporting of data to registries has
demonstrated limitations. The health authorities can choose among
several options to encourage physicians and healthcare institutions
to contribute data to registries. One option may  consist in includ-
ing participation in a registry among the criteria used by the French
National Health Authority (Haute Autorité de santé, HAS) to certify
healthcare institutions. Participation in registries could be included
in contracts established with the regional health agencies (Agence
régionale de santé, ARS). Healthcare institutions that fail to report
data to registries would lose their accreditation for the implanta-
tion of the relevant devices [2]. Finally, making reimbursement of
the implant and surgical procedure conditional on data reporting
to registries would be a powerful tool.
9. Conclusion
The creation of registries of implantable medical devices ensures
effective post-marketing surveillance and allows the detection of
defects before they translate into public health disasters magniﬁed
by the media. Although registries are not the only effective tool for
monitoring medical devices, well-designed registries that receive
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roper input from healthcare professionals are among the most
owerful post-marketing surveillance methods available to date.
egistries are a manifestation of the evaluation culture. Thus, their
idespread development in some countries (such as Scandinavian,
ustralia, UK) and their virtual absence in others (such as southern
uropean countries) highlights the impact of cultural differences on
ealthcare evaluation. France is far behind many other countries,
ost notably in the ﬁeld of orthopaedics.
Registries have provided a wealth of information to the surgi-
al community via the development of electronic communication
ethods and the widespread use of English to report healthcare
ata. At the individual level, registries allow each surgeon to com-
are his or her practice to that of the overall community of surgeons
n the same specialty. At the national level, registries provide
nique information on the performance of implants and healthcare
nstitutions, which policy-makers will soon consider indispensable.
his maturity of the actors involved is a key factor for the devel-
pment of registries aimed at achieving overall improvements in
rofessional practice and thereby at improving the quality of care
elivered to patients scheduled for surgery.
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